Health Revenue Assurance Holdings, Inc.
HRAA • Medical - Healthcare Plans
$0.02
— 0.00 (0.00%)
Current price
EarningsLatest report: Sep 30, 2025
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.52M
Growth
20.5%
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 5.1%Weak liquidity · 0.43Weak profitability
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Nov 12, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.02
Change0.00%
Shares Out89.35M
Market Cap$1.52M
Enterprise Value$8.68M
52W Range0.04 - 0.06
Beta-2.34
P/E-0.53
P/S0.06
P/B-0.39
P/FCF-0.59
EV/Sales0.32
Price$0.02
Change0.00%
Shares Out89.35M
Market Cap$1.52M
Enterprise Value$8.68M
52W Range0.04 - 0.06
Beta-2.34
P/E-0.53
P/S0.06
P/B-0.39
P/FCF-0.59
EV/Sales0.32
EV/EBITDA-6.37
EV/FCF-3.35
Earnings Yield-188.99%
FCF Yield-170.81%
Dividend Yield0.00%
Gross Margin11.34%
Oper. Margin-12.87%
Profit Margin-8.84%
Debt/Eq-2.92
Current Ratio0.43
Quick Ratio0.43
Revenue 5Y20.50%
Volume1.71M
Avg Volume27.48K
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
70/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Positive revenue growth · 5.1%Weak liquidity · 0.43Weak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.